Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
HRS-1167 by Merck for Castration-Resistant Prostate Cancer (CRPC): Likelihood of Approval
HRS-1167 is under clinical development by Merck and currently in Phase I for Castration-Resistant Prostate Cancer (CRPC). According to GlobalData,...
Data Insights
HRS-1167 by Merck for Ovarian Cancer: Likelihood of Approval
HRS-1167 is under clinical development by Merck and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I...